The pharmaceutical excipients market size has grown strongly in recent years. It will grow from $10.25 trillion in 2024 to $10.92 trillion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to strong economic growth in emerging markets, a surge in the sale of generic drugs and rising advanced healthcare infrastructure.
The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $14.26 trillion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to government initiatives, an increasing development of novel drugs, rising healthcare expenditure and a rapid growth in the elderly population will drive market growth. Major trends in the forecast period include focusing on sustainable packaging to reduce the use of plastics, focusing on mergers and acquisitions to strengthen market position, focusing on reducing greenhouse gas emissions and leveraging artificial intelligence to track nutrients, water levels and improve transparency in supply chains.
The global upswing in generic drug sales has played a pivotal role in the expansion of the pharmaceutical excipients market. Generic drugs serve as alternatives to branded medications, maintaining the same dosage form, safety, strength, route of administration, and quality. India, as noted by the India Brand Equity Foundation (IBEF), stands out as the largest contributor to generic medicines globally, with its generic drugs constituting 20% of the total global exports in this category. Notably, Indian pharmaceutical companies secured 300 approvals for generic drugs in the USA, further fueling the pharmaceutical excipients market due to increased demand for generic drugs.
The increasing sales of biologics are anticipated to drive growth in the pharmaceutical sterility testing market in the coming years. Biologics, or biological products, refer to medicines derived from living organisms and encompass a range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are employed in biologics to enhance stability, improve formulation, and ensure optimal delivery of active biological agents. For example, a report from the European Pharmaceutical Review in May 2022 projected that biologics sales will significantly exceed those of innovative small molecules over the next five years, with biologics expected to generate an additional $120 billion in sales by 2027. As a result, the rise in biologics sales is contributing to the growth of the pharmaceutical excipients market.
Major companies in the pharmaceutical excipient market are developing advanced excipients, such as high-purity excipients, to improve drug formulation stability, enhance bioavailability, and facilitate complex drug delivery systems. High-purity excipients are pharmaceutical excipients that have undergone advanced purification processes to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical company based in Switzerland, introduced three new VitiPure excipients aimed at enhancing the stability and solubility of active pharmaceutical ingredients (APIs). These products include VitiPure O 80 Superior, a high-purity polysorbate 80, VitiPure CO 35 Superior, a polyoxyl 35 castor oil, and VitiPure Meglumine LEX, a solubilizer with low bioburden. Designed for various drug delivery applications, particularly for sensitive formulations like mRNA vaccines and biologics, these excipients respond to the increasing demand for high-purity ingredients while complying with stringent regulatory standards.
Key players in the pharmaceutical excipient market are introducing advanced excipients such as Apisolex to streamline manufacturing processes and minimize losses of active pharmaceutical ingredients (APIs). Apisolex, an innovative solubility-enhancing excipient technology, addresses and overcomes solubility challenges. In a notable example from March 2022, Lubrizol Life Science (LLS) Health, a pharmaceutical contract development and drug product manufacturing organization based in the US, launched Apisolex to enhance solubility and simplify the manufacturing of parenteral drug products. This excipient can significantly increase solubility, support high drug loading, and optimize manufacturing by reducing API loss and ensuring efficient encapsulation.
In March 2024, Roquette, a France-based manufacturer of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for $2.85 billion. This acquisition positions Roquette as a preferred partner in the pharmaceutical industry, with the goal of addressing evolving customer needs and enhancing patient outcomes through improved treatment options. IFF Pharma Solutions is a US-based company that specializes in producing pharmaceutical excipients and specialty solutions for the pharmaceutical sector.
Major companies operating in the pharmaceutical excipients market include BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Actelion Pharmaceuticals UK Ltd, Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma.
North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Pharmaceutical excipients are non-active pharmaceutical ingredients (API) that form part of a drug delivery system and have undergone rigorous safety evaluations. While not possessing inherent activity, these excipients play a crucial role in facilitating the administration of the drug in the correct form and supporting its mode and site of action.
Pharmaceutical excipients come in various types, with the primary categories being inorganic chemicals, organic chemicals, and others. The pharmaceutical inorganic chemical sector focuses on the manufacturing, physical or chemical characteristics, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. These excipients serve different functionalities, including but not limited to fillers and diluents, suspending and viscosity agents, coating agents, flavoring agents, sweeteners, disintegrants, colorants, lubricants, glidants, and others. Additionally, they are utilized in diverse formulations such as oral, topical, and parental formulations.
The pharmaceutical excipients market research report is one of a series of new reports that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $14.26 trillion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to government initiatives, an increasing development of novel drugs, rising healthcare expenditure and a rapid growth in the elderly population will drive market growth. Major trends in the forecast period include focusing on sustainable packaging to reduce the use of plastics, focusing on mergers and acquisitions to strengthen market position, focusing on reducing greenhouse gas emissions and leveraging artificial intelligence to track nutrients, water levels and improve transparency in supply chains.
The global upswing in generic drug sales has played a pivotal role in the expansion of the pharmaceutical excipients market. Generic drugs serve as alternatives to branded medications, maintaining the same dosage form, safety, strength, route of administration, and quality. India, as noted by the India Brand Equity Foundation (IBEF), stands out as the largest contributor to generic medicines globally, with its generic drugs constituting 20% of the total global exports in this category. Notably, Indian pharmaceutical companies secured 300 approvals for generic drugs in the USA, further fueling the pharmaceutical excipients market due to increased demand for generic drugs.
The increasing sales of biologics are anticipated to drive growth in the pharmaceutical sterility testing market in the coming years. Biologics, or biological products, refer to medicines derived from living organisms and encompass a range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are employed in biologics to enhance stability, improve formulation, and ensure optimal delivery of active biological agents. For example, a report from the European Pharmaceutical Review in May 2022 projected that biologics sales will significantly exceed those of innovative small molecules over the next five years, with biologics expected to generate an additional $120 billion in sales by 2027. As a result, the rise in biologics sales is contributing to the growth of the pharmaceutical excipients market.
Major companies in the pharmaceutical excipient market are developing advanced excipients, such as high-purity excipients, to improve drug formulation stability, enhance bioavailability, and facilitate complex drug delivery systems. High-purity excipients are pharmaceutical excipients that have undergone advanced purification processes to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical company based in Switzerland, introduced three new VitiPure excipients aimed at enhancing the stability and solubility of active pharmaceutical ingredients (APIs). These products include VitiPure O 80 Superior, a high-purity polysorbate 80, VitiPure CO 35 Superior, a polyoxyl 35 castor oil, and VitiPure Meglumine LEX, a solubilizer with low bioburden. Designed for various drug delivery applications, particularly for sensitive formulations like mRNA vaccines and biologics, these excipients respond to the increasing demand for high-purity ingredients while complying with stringent regulatory standards.
Key players in the pharmaceutical excipient market are introducing advanced excipients such as Apisolex to streamline manufacturing processes and minimize losses of active pharmaceutical ingredients (APIs). Apisolex, an innovative solubility-enhancing excipient technology, addresses and overcomes solubility challenges. In a notable example from March 2022, Lubrizol Life Science (LLS) Health, a pharmaceutical contract development and drug product manufacturing organization based in the US, launched Apisolex to enhance solubility and simplify the manufacturing of parenteral drug products. This excipient can significantly increase solubility, support high drug loading, and optimize manufacturing by reducing API loss and ensuring efficient encapsulation.
In March 2024, Roquette, a France-based manufacturer of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for $2.85 billion. This acquisition positions Roquette as a preferred partner in the pharmaceutical industry, with the goal of addressing evolving customer needs and enhancing patient outcomes through improved treatment options. IFF Pharma Solutions is a US-based company that specializes in producing pharmaceutical excipients and specialty solutions for the pharmaceutical sector.
Major companies operating in the pharmaceutical excipients market include BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Actelion Pharmaceuticals UK Ltd, Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma.
North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Pharmaceutical excipients are non-active pharmaceutical ingredients (API) that form part of a drug delivery system and have undergone rigorous safety evaluations. While not possessing inherent activity, these excipients play a crucial role in facilitating the administration of the drug in the correct form and supporting its mode and site of action.
Pharmaceutical excipients come in various types, with the primary categories being inorganic chemicals, organic chemicals, and others. The pharmaceutical inorganic chemical sector focuses on the manufacturing, physical or chemical characteristics, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. These excipients serve different functionalities, including but not limited to fillers and diluents, suspending and viscosity agents, coating agents, flavoring agents, sweeteners, disintegrants, colorants, lubricants, glidants, and others. Additionally, they are utilized in diverse formulations such as oral, topical, and parental formulations.
The pharmaceutical excipients market research report is one of a series of new reports that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pharmaceutical Excipients Market Characteristics3. Pharmaceutical Excipients Market Trends and Strategies4. Pharmaceutical Excipients Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Pharmaceutical Excipients Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Pharmaceutical Excipients Market34. Recent Developments in the Pharmaceutical Excipients Market
5. Global Pharmaceutical Excipients Growth Analysis and Strategic Analysis Framework
6. Pharmaceutical Excipients Market Segmentation
7. Pharmaceutical Excipients Market Regional and Country Analysis
8. Asia-Pacific Pharmaceutical Excipients Market
9. China Pharmaceutical Excipients Market
10. India Pharmaceutical Excipients Market
11. Japan Pharmaceutical Excipients Market
12. Australia Pharmaceutical Excipients Market
13. Indonesia Pharmaceutical Excipients Market
14. South Korea Pharmaceutical Excipients Market
15. Western Europe Pharmaceutical Excipients Market
16. UK Pharmaceutical Excipients Market
17. Germany Pharmaceutical Excipients Market
18. France Pharmaceutical Excipients Market
19. Italy Pharmaceutical Excipients Market
20. Spain Pharmaceutical Excipients Market
21. Eastern Europe Pharmaceutical Excipients Market
22. Russia Pharmaceutical Excipients Market
23. North America Pharmaceutical Excipients Market
24. USA Pharmaceutical Excipients Market
25. Canada Pharmaceutical Excipients Market
26. South America Pharmaceutical Excipients Market
27. Brazil Pharmaceutical Excipients Market
28. Middle East Pharmaceutical Excipients Market
29. Africa Pharmaceutical Excipients Market
30. Pharmaceutical Excipients Market Competitive Landscape and Company Profiles
31. Pharmaceutical Excipients Market Other Major and Innovative Companies
35. Pharmaceutical Excipients Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Pharmaceutical Excipients Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pharmaceutical excipients? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical excipients market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products2) By Functionality: Fillers and Diluents, Suspending and Viscosity Agents, Coating Agents, Binders, Flavoring Agents and Sweeteners, Disintegrants, Colorants, Lubricants and Glidants, Other Functionalities
3) By Type of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts; Oxides; Silicates2) By Organic Chemicals: Sugars; Polymers; Oils and Fats
3) By Other Products: Natural Excipients; Coatings; Antioxidants
Key Companies Mentioned: BASF SE; Ashland Global Holdings; Evonik Industries AG; International Flavors & Fragrances, Inc; Roquette Frères
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- BASF SE
- Ashland Global Holdings
- Evonik Industries AG
- International Flavors & Fragrances, Inc
- Roquette Frères
- Archer Daniels Midland Company
- Lubrizol Corporation
- Croda International Plc
- Kerry Group
- DuPont de Nemours, Inc.
- Sun Pharmaceuticals Industries Ltd
- Cipla Ltd
- Amster Microcell Private Limited
- Finar Limited
- P. D. Polychem Private Limited
- CAD Pharma Inc
- Maas Pharma Chemicals
- Aeon Procare Private Limited
- CSPC Pharmaceutical Group Ltd
- Allen & Hanburys Ltd
- Actelion Pharmaceuticals UK Ltd
- Colorcon
- MEGGLE GmbH & Co. KG
- Boehringer Ingelheim International GmbH
- DMV-Fonterra Excipients GmbH & Co. KG
- Alpen Pharma AG
- Avantor Inc
- JRS PHARMA GmbH & Co. KG
- The Dow Chemical Co
- Pfizer
- AbbVie Inc
- EMS Pharma
- Biolab Farmaceutica
- Medist FZE
- W.R. Grace
- Univar Solutions
- Nitika Pharma
- DFE Pharma
- Cargill
- Sensient Pharma
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 10.92 Trillion |
| Forecasted Market Value ( USD | $ 14.26 Trillion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 40 |
